Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

High-power laser treatment for meralgia paresthetica

Official title: The Efficacy of High-Power Laser Therapy as an Adjunct to Conservative Management in Patients With Meralgia Paresthetica: A Randomized, Assessor-Blinded, Controlled Trial

Run by Uşak University · NCT07328360 · Data updated 2026-11-12

This trial will try high-power laser therapy alongside usual care to see if it reduces pain, tingling, and functional limits in adults with chronic meralgia paresthetica.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorUşak University
Academic / other
Locations1 site (Uşak)
StatusRecruiting
StartedJanuary 12, 2026
Main results expectedJuly 5, 2026
Study endsAugust 5, 2026
Registry record updatedJanuary 13, 2026
Trial IDNCT07328360 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with clinically diagnosed chronic meralgia paresthetica lasting ≥3 months and baseline pain ≥4 on the NRS are the target participants.

Probably not a fit

Patients with secondary meralgia paresthetica (for example due to surgery or tumor), significant lumbar radiculopathy, bleeding disorders, pregnancy, pacemakers, or active skin disease at the treatment site are unlikely to benefit or may be ineligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In a randomized, sham-controlled, assessor-blinded design, adults with chronic meralgia paresthetica will receive either active high-power laser therapy or a sham procedure in addition to standard conservative care. Primary outcomes include changes in pain intensity, dysesthetic sensory symptoms, and functional capacity measured over the treatment and follow-up period. Eligible participants are 18–65 years old with at least three months of symptoms and a baseline pain score ≥4, while those with secondary causes, significant lumbar radiculopathy, bleeding disorders, pregnancy, or implanted pacemakers are excluded. The trial is conducted at Uşak University with collaboration from Balikesir University and uses standardized treatment protocols and blinded outcome assessment to limit bias.

Why it matters

Potential benefit: If effective, high-power laser therapy could reduce pain and sensory symptoms and improve daily function without resorting to invasive surgery.

How similar studies have gone: Some small trials of laser therapy for peripheral neuropathic pain have reported benefit, but high-power laser treatment specifically for meralgia paresthetica has limited prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18-65 years.
* Clinical diagnosis of MP (based on history: burning pain, tingling, numbness in the lateral thigh; tenderness over the inguinal ligament near the anterior superior iliac spine (ASIS); and a positive pelvic compression test or Tinel's sign over the lateral femoral cutaneous nerve (LFCN)).
* Symptoms persistent for at least 3 months (chronic).
* A baseline pain intensity of ≥4 on the Numeric Rating Scale (NRS).

Exclusion Criteria:

* Secondary MP (e.g., due to pelvic surgery, trauma, or tumor mass effect confirmed by imaging).
* Significant lumbar radiculopathy (L1-L2).
* Coagulopathy, use of anticoagulants.
* Pregnancy.
* Skin disease or infection in the treatment area.
* Presence of a cardiac pacemaker.
* Severe cognitive impairment.

Where it's running

  • Usak University
    Uşak, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.